BioNAV

Proprietary computational AI platform that generates Living Molecular Twins, digital twins of patients, from patient RNA. It screens 40,000+ molecules in silico to predict drug efficacy, stratify responders, discover targets and mechanisms, and support drug repurposing and clinical translation.